Surveillance: 252 Real Stories

252 stories match surveillance. 199 of them mention surgery.

LA
Breast Cancer

Locally advanced male breast cancer associated with a pathogenic ATM variant

Patient Info: Anonymized, Male, 50s | Stage Metastatic/Advanced

Biomarkers: ER 100% positive; PR 100% positive; HER2-negative; Ki-67 30%; germline pathogenic ATM variant c.2921+1G>A.

Two years after diagnosis, he had an ECOG performance status of 0 and remained without signs of breast-cancer relapse or another primary cancer.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage I Colorectal AdenocarcinomaColorectal Cancer

Perforated appendicitis after surgery for stage I rectal cancer

Patient Info: Anonymized, Male, 70+ | Stage I

He recovered well after appendicectomy, was doing well at the four-week review, and remained under intensive rectal-cancer follow-up with community stoma and wound-care support.

PubMed Central
OutcomeCare Ongoing
Deborah, who was diagnosed with Stage I Lung CancerLung Cancer

Stage I Lung Cancer: Deborah's Patient Story

Patient Info: Deborah Schroeder, Female | Stage I

As of December 2020, Deborah had completed 3 separate 4-day SBRT courses for Stage I lung cancers and remained under monitoring for about 10 tiny lung nodules that had been stable for years.

MD Anderson
OutcomeCare Ongoing
Allison, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Allison's Survivor Story

Patient Info: Allison, Female, Under 40 | Stage III

As of August 2020, Allison reported no evidence of disease on follow-up scans while continuing survivorship care after rectal-cancer treatment.

The Patient Story
OutcomeCancer-Free / NED
Brooks, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Brooks's Survivor Story

Patient Info: Brooks Bell, Female | Stage III

As of July 2020, Brooks had no cancer found during follow-up colonoscopy, though new polyps were removed or biopsied and repeat colonoscopy was recommended in 1 year because polyps appeared to return quickly.

Colorectal Cancer Alliance
OutcomeCancer-Free / NED
Shannon, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Cancer Survivor Story: Colon Cancer (Lynch Syndrome)

Patient Info: Shannon, Female, Under 40 | Stage II

Biomarkers: Lynch syndrome; MSI-high / dMMR

As of May 2020, Shannon was considered cancer-free after surgery-only treatment for Stage IIA MSI-high/Lynch-associated colon cancer and remained on strict Lynch syndrome surveillance.

The Patient Story
OutcomeCancer-Free / NED
Barbara, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Colon Cancer Stories: Barbara Majeski

Patient Info: Barbara Majeski, Female, 40s | Stage III

As of May 2020, Barbara was approaching the 5-year mark after Stage III colon cancer, with blood tests every 6 months and annual scans reported as good/clear.

The Patient Story
OutcomeCancer-Free / NED
MS
Lung Cancer

Multifocal stage IIIA lung adenocarcinoma responding to nivolumab

Patient Info: Anonymized, Female, 60s | Stage III

Biomarkers: CK7-positive; TTF-1-positive; napsin-A-positive; PD-L1 85% positive.

The biopsied lung nodule nearly resolved after four nivolumab cycles, and the remaining pulmonary nodules were stable at 24 months.

PubMed Central
OutcomeResponding Well
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

Surgery for an isolated splenic metastasis from lung adenocarcinoma

Patient Info: Anonymized, Female, 70+ | Stage IV

Metastatic Site: spleen

Nine months after removal of the isolated splenic metastasis, follow-up showed no local or disseminated recurrence and she remained under regular lung-cancer surveillance.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Small Cell Lung CancerLung Cancer

More than 10 years living with relapsing extensive-stage small cell lung cancer

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: Chromogranin-positive.

Metastatic Site: pleura; pancreas; left kidney and perinephric region

After five treatment lines and several metastatic relapses over more than 10 years, his latest irinotecan and carboplatin course produced another partial response and he was doing well at the last follow-up.

PubMed Central
OutcomeResponding Well
A patient, who was diagnosed with Stage I Invasive Lobular CarcinomaBreast Cancer

Early breast cancer followed 19 years later by a radiation-related breast sarcoma

Patient Info: Anonymized, Female, 70+ | Stage I

Biomarkers: Strongly ER-positive; strongly PR-positive.

The stage IA breast carcinoma remained disease-free for 19 years; a later right-breast mass was a separate radiation-induced sarcoma rather than recurrent carcinoma.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Small Cell Lung CancerLung Cancer

Small cell lung cancer found through a disabling paraneoplastic neuropathy

Patient Info: Anonymized, Female, 60s

Biomarkers: Anti-CRMP5 antibody-positive.

She completed chemotherapy and radiation and entered oncology follow-up, while the disabling sensory and motor neuropathy persisted and rehabilitation continued.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Stage III Invasive Ductal CarcinomaBreast Cancer

Dramatic chemotherapy response in stage IIIB triple-negative breast cancer

Patient Info: Anonymized, Female, 40s | Stage III

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1-negative; BRCA2-negative; germline FLCN c.1285delC associated with Birt-Hogg-Dubé syndrome; tumor TP53 p.T150fs.

Eighteen months after surgery, she had no recurrence following a dramatic chemotherapy response, bilateral mastectomy, chest-wall radiation, and adjuvant capecitabine.

PubMed Central
OutcomeCancer-Free / NED
Constance, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Constance's Survivor Story

Patient Info: Constance Porter, Female

As of January 2020, Constance was cancer-free 3 years after breast cancer diagnosis, while living with permanent hair loss, joint pain from anastrozole, and occasional leg cramps.

MD Anderson
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

A uterine mass revealed a rare metastasis from lung adenocarcinoma

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: CK7-positive; TTF-1-positive; CK20-negative; PAX8-negative; GATA3-negative.

Metastatic Site: uterus within a leiomyoma

Twelve months after removal of the uterine metastasis, she remained well with normal surveillance imaging and no concern for recurrent disease.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage I Colorectal AdenocarcinomaColorectal Cancer

Stage I colon cancer found during treatment planning for breast cancer

Patient Info: Anonymized, Female, 50s | Stage I

Biomarkers: MSH2, MSH6, MLH1, and PMS2 expression preserved.

Two years after surgery, she remained well with no CT evidence of metastatic disease or recurrence while continuing six-monthly follow-up.

PubMed Central
OutcomeCancer-Free / NED
Anatole, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Anatole's Survivor Story

Patient Info: Anatole Karpovs, Male, Under 40 | Stage IV

Metastatic Site: Liver

As of October 2018, Anatole had no evidence of disease after liver surgery and FOLFIRI for a July 2014 liver recurrence, and had been cancer-free for almost 4 years while recognizing that microscopic disease could still be possible.

MD Anderson
OutcomeCancer-Free / NED